Adaptimmune Therapeutics
ADAP
#9328
Rank
$66.39 M
Marketcap
$0.26
Share price
-20.31%
Change (1 day)
-81.02%
Change (1 year)

P/S ratio for Adaptimmune Therapeutics (ADAP)

P/S ratio as of April 2025 (TTM): 0.3729

According to Adaptimmune Therapeutics's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 5.60. At the end of 2024 the company had a P/S ratio of 0.8480.

P/S ratio history for Adaptimmune Therapeutics from 2016 to 2024

PS ratio at the end of each year

Year P/S ratio Change
20240.8480-71.62%
20232.99-66.09%
20228.81-90.75%
202195.3-54.81%
202021187.41%
20191121013.07%
201810.1-38.91%
201716.5-18.08%
201620.2

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
1.47 294.54%๐Ÿ‡บ๐Ÿ‡ธ USA
0.5223 40.06%๐Ÿ‡บ๐Ÿ‡ธ USA
21.4 5,628.27%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
4.46 1,096.35%๐Ÿ‡บ๐Ÿ‡ธ USA